Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.37

+0.9%

Dec 8 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (4544)	8/27/2001 11:28:41 AM
From: Biomaven	Read Replies (3) of 52153

Well, looks like that TSC attack on BPUR may have been unfounded: Message 16263911 See my earlier comment on this thread: Message 16215097 What conceivably might have happened is that there were indeed adverse effects with the BPUR product that were picked up by the TSC "contributors," but there were a similar number in the group receiving blood. That's the charitable view on TSC - the less charitable view is that the shorts wanted to cover at low prices and they fed TSC a distorted story. Note I don't yet see any coverage of today's news from TSC... Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next